AhmedMahmoud_MD Profile Banner
Ahmed K. Mahmoud Profile
Ahmed K. Mahmoud

@AhmedMahmoud_MD

Followers
868
Following
11K
Media
132
Statuses
4K

🇪🇬| Resident Physician @BUMedicine @BMC_Brighton | Researcher @MayoclinicCV | Cardiologist in the Making🫀| Passionate by #MedEd and Cooking

Boston, MA
Joined January 2011
Don't wanna be here? Send us removal request.
@AhmedMahmoud_MD
Ahmed K. Mahmoud
4 months
That was a great interview!!!.Wait for the full report on the youtube channel. @MayoClinicCV @MayoAZCVFellows.
@FITsOnTheGo
FITsOnTheGo
4 months
Dapagliflozin in TAVI patients — a pragmatic trial tackling real world outcomes. We spoke with the lead investigator @S_Raposeiras at #ACC25 to hear firsthand insights into this exciting study. @AhmedMahmoud_MD @MayoClinicCV
0
1
7
@AhmedMahmoud_MD
Ahmed K. Mahmoud
19 hours
RT @purviparwani: Excited to give Grand Rounds at Mayo Clinic Arizona (@MayoClinicAZID) tomorrow! Had a lovely dinner tonight catching up w….
0
10
0
@AhmedMahmoud_MD
Ahmed K. Mahmoud
9 days
RT @rcogswell_umn: 🚨 Now recruiting! One application = Advanced HF + Critical Care Cardiology Dual Track Fellowship 🎯. ❤️ Legendary CV tea….
Tweet card summary image
sites.google.com
Advanced Heart Failure & Transplantation/Cardiac Critical Care Medicine Dual-Track Pathway For trainees seeking to complete fellowships in both Advanced Heart Failure (AHF) and Critical Care Medicine...
0
10
0
@AhmedMahmoud_MD
Ahmed K. Mahmoud
11 days
Quick review of EastAFNET trial which favors Rhythm control vs old AFFIRM trial!!.
@NEJM
NEJM
5 years
Quick Take: Reducing Cardiovascular Risk in Atrial Fibrillation
0
0
4
@AhmedMahmoud_MD
Ahmed K. Mahmoud
14 days
Our study on Lp(a) variability highlights the change of Lp(a) over time!. While repeat testing may aid risk assessment, it does not impact management, as no treatments have shown outcome benefit in elevated Lp(a). @Kamal_Awad733.
@EJPCEiC
EJPC Editor-in-Chief
14 days
How stable is your Lp(a)?.In >11,000 patients, borderline Lp(a) levels (30–50 mg/dL) often changed over time, especially in women, those with ASCVD, on statins, or with high LDL-C. 📊 Repeated testing may be key for accurate risk assessment. 🔗 Read more:
Tweet media one
0
1
8
@AhmedMahmoud_MD
Ahmed K. Mahmoud
16 days
Full support for our chief, well deserved Ibrahim 👏🏻👏🏻.
@Ibrahim_Kamel9
Ibrahim Kamel
16 days
Cardiology Fellowship app: sent. ECGs, cath labs, and caffeine—ready for the next adventure. Let’s see where this heart leads me. Grateful for all the support and mentorship along the way.🫀✨! 💙🫀 #Cardiology #MedTwitter #FellowshipMatch #CardioTwitter #Match2026
Tweet media one
0
0
3
@AhmedMahmoud_MD
Ahmed K. Mahmoud
28 days
RT @M_H_Abdelnabi: Great collaboration at @MayoClinicCV with our stellar @AhmedMahmoud_MD . GLP-1RA + SGLT2i therapy was associated with si….
0
1
0
@AhmedMahmoud_MD
Ahmed K. Mahmoud
29 days
New guidelines for assessing Diastolic Dysfunction and diagnosing HFpEF by @ASE360 . For more information read the full statement:
Tweet media one
1
17
57
@AhmedMahmoud_MD
Ahmed K. Mahmoud
29 days
Lower rates of:. • Ischemic stroke (8.0 % vs 11.3 %; HR 0.64, p = 0.0083). • Heart failure exacerbations (19.1 % vs 29.0 %; HR 0.57, p < 0.0001) . • All-cause hospitalization (24.8 % vs 30.6 %; HR 0.70, p = 0.0004). • No increase in AF or ventricular arrhythmia.
0
0
0
@AhmedMahmoud_MD
Ahmed K. Mahmoud
29 days
GLP-1RA + SGLT2i therapy was associated with significantly improved outcomes at 12-month follow-up, . • Lower all-cause mortality (1.8 % vs 5.5 %; HR 0.30, p < 0.0001). • Reduced MACE (14.0 % vs 19.3 %; HR 0.64, p = 0.0006). compared to SGLT2i therapy alone.
Tweet media one
1
0
1
@AhmedMahmoud_MD
Ahmed K. Mahmoud
29 days
🚨Publication Alert 🚨 . 🎉 Excited to share our new publication on the effects of GLP-1 RA in cardiac amyloidosis, now out in @IJCardio . @Ibrahim_Kamel9 @Kamal_Awad733 .@ramziw_ @M_H_Abdelnabi @hoangnhat_pham @ChadiAyoub1 . Read here: #CardioTwitter 🧵
Tweet media one
1
5
26
@AhmedMahmoud_MD
Ahmed K. Mahmoud
1 month
RT @AdhamGR97: NY Valves- It’s been a pleasure!.Grateful for the opportunity to present and learn alongside such brilliant minds. Huge th….
0
4
0
@AhmedMahmoud_MD
Ahmed K. Mahmoud
1 month
RT @droos_online: What moves improves, .أو زي ما بيقولوا عندنا : الحركة بركة. السكون والقاعدة والفراغ بيخليك فريسة سهلة للأفكار السلبية و….
0
817
0
@AhmedMahmoud_MD
Ahmed K. Mahmoud
2 months
RT @panagis21: Brought my dad to work today. A retired union painter, all he did was stare at my degrees 😊 . Degrees that wouldn’t be possi….
0
14K
0
@AhmedMahmoud_MD
Ahmed K. Mahmoud
2 months
RT @AhmedyounesMD: 🧵 Check out our new Study.1/. Anticoagulation is central to AF management, but what happens when the patient has thrombo….
0
3
0
@AhmedMahmoud_MD
Ahmed K. Mahmoud
2 months
Honored to be named Intern of the Year! Very grateful for my mentors. Excited for what’s ahead! .@BUMedicine @bmc_brighton
Tweet media one
2
1
33
@AhmedMahmoud_MD
Ahmed K. Mahmoud
3 months
RT @BMCSouthIM: Our residents had an incredible showing at the BMC-Brighton Annual Research Day — with 7 poster presentations and a 1️⃣st p….
0
2
0
@AhmedMahmoud_MD
Ahmed K. Mahmoud
3 months
RT @AmiBhattMD: Imagine heart surgery without cracking open the chest. Sounds impossible, right?. But in 2002, Dr. Alain Cribier made it a….
0
244
0
@AhmedMahmoud_MD
Ahmed K. Mahmoud
3 months
RT @Ibrahim_Kamel9: Excited to present 3 studies at #SCAI2025 in D.C.!.•SCAD: Teaching vs. non-teaching (May 2 @ 1:25 PM).•TAVR vs SAVR (Ma….
0
2
0
@AhmedMahmoud_MD
Ahmed K. Mahmoud
3 months
Finally, TAVR for Asymptomatic severe AS 🙌🏻🙌🏻.
0
0
2
@AhmedMahmoud_MD
Ahmed K. Mahmoud
3 months
RT @The_BMC: New Names. Renewed Commitment. St. Elizabeth’s is now @bmc_brighton, and Good Samaritan is now @bmc_south. We are united thro….
0
6
0